Nanosized functional miRNA liposomes and application in the treatment of TNBC by silencing Slug gene

References

• Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer. New Eng J Med. 2010;363(20):1938–1948. doi:10.1056/NEJMra100138921067385
   PubMed Web of Science ®Google Scholar
• Lehmann BD, Bauer JA, Chen X, et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest. 2011;121(7):2750–2767. doi:10.1172/JCI5787321633166
   PubMed Web of Science ®Google Scholar
• Granados-Principal S, Liu Y, Guevara ML, et al. Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer. Breast Cancer Res. 2015;17:25. doi:10.1186/s13058-015-0527-x25849745
   PubMed Web of Science ®Google Scholar
• Albergaria A, Ricardo S, Milanezi F, et al. Nottingham Prognostic Index in triple-negative breast cancer: a reliable prognostic tool? BMC Cancer. 2011;11:299. doi:10.1186/1471-2407-11-29921762477
   PubMed Web of Science ®Google Scholar
• Ambros V. The functions of animal microRNAs. Nature. 2004;431(7006):350–355. doi:10.1038/nature0287115372042
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–297. doi:10.1016/S0092-8674(04)00045-514744438
   PubMed Web of Science ®Google Scholar
• Bartel DP. Metazoan microRNAs. Cell. 2018;173(1):20–51. doi:10.1016/j.cell.2018.03.00629570994
   PubMed Web of Science ®Google Scholar
• Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017;16(3):203–222. doi:10.1038/nrd.2016.24628209991
   PubMed Web of Science ®Google Scholar
• Mathiyalagan P, Sahoo S. Exosomes-based gene therapy for microRNA delivery. Methods Mol Biol. 2017;1521:139–152. doi:10.1007/978-1-4939-6588-5_927910046
   PubMedGoogle Scholar
• Rhim H, Savagner P, Thibaudeau G, Thiery JP, Pavan WJ. Localization of a neural crest transcription factor, Slug, to mouse chromosome 16 and human chromosome 8. Mamm Genome. 1997;8(11):872–873.9337409
   PubMed Web of Science ®Google Scholar
• Cohen ME, Yin M, Paznekas WA, Schertzer M, Wood S, Jabs EW. Human SLUG gene organization, expression, and chromosome map location on 8q. Genomics. 1998;51(3):468–471. doi:10.1006/geno.1998.53679721220
   PubMedGoogle Scholar
• Richter A, Valdimarsdottir L, Hrafnkelsdottir HE, et al. BMP4 promotes EMT and mesodermal commitment in human embryonic stem cells via SLUG and MSX2. Stem Cells. 2014;32(3):636–648. doi:10.1002/stem.159224549638
   PubMed Web of Science ®Google Scholar
• Bai L, Chang HM, Zhu YM, Leung PCK. Bone morphogenetic protein 2 increases lysyl oxidase activity via up-regulation of snail in human granulosa-lutein cells. Cell Signal. 2019;53:201–211. doi:10.1016/j.cellsig.2018.10.00930321593
   PubMedGoogle Scholar
• Chang TH, Tsai MF, Su KY, et al. Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor. Am J Respir Crit Care Med. 2011;183(8):1071–1079. doi:10.1164/rccm.201009-1440OC21037017
   PubMed Web of Science ®Google Scholar
• Findlay VJ, Wang C, Nogueira LM, et al. SNAI2 modulates colorectal cancer 5-fluorouracil sensitivity through miR145 repression. Mol Cancer Ther. 2014;13(11):2713–2726. doi:10.1158/1535-7163.MCT-14-020725249558
   PubMed Web of Science ®Google Scholar
• Ferrari-Amorotti G, Chiodoni C, Shen F, et al. Suppression of invasion and metastasis of triple-negative breast cancer lines by pharmacological or genetic inhibition of slug activity. Neoplasia. 2014;16(12):1047–1058. doi:10.1016/j.neo.2014.10.00625499218
   PubMed Web of Science ®Google Scholar
• Laakkonen P, Porkka K, Hoffman JA, Ruoslahti E. A tumor-homing peptide with a targeting specificity related to lymphatic vessels. Nat Med. 2002;8(7):751–755. doi:10.1038/nm72012053175
   PubMed Web of Science ®Google Scholar
• Laakkonen P, Akerman ME, Biliran H, et al. Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells. Proc Natl Acad Sci U S A. 2004;101(25):9381–9386. doi:10.1073/pnas.040331710115197262
   PubMed Web of Science ®Google Scholar
• Roth L, Agemy L, Kotamraju VR, et al. Transtumoral targeting enabled by a novel neuropilin-binding peptide. Oncogene. 2012;31(33):3754–3763. doi:10.1038/onc.2011.53722179825
   PubMed Web of Science ®Google Scholar
• Dong P, Cai H, Chen L, et al. Biodistribution and evaluation of 131 I-labeled neuropilin-binding peptide for targeted tumor imaging. Contrast Media Mol Imaging. 2016;11(6):467–474. doi:10.1002/cmmi.170827527756
   PubMedGoogle Scholar
• Liang DS, Su HT, Liu YJ, Wang AT, Qi XR. Tumor-specific penetrating peptides-functionalized hyaluronic acid-d-α-tocopheryl succinate based nanoparticles for multi-task delivery to invasive cancers. Biomaterials. 2015;71:11–23. doi:10.1016/j.biomaterials.2015.08.03526310359
   PubMed Web of Science ®Google Scholar
• Choi KM, Kwon IC, Ahn HJ. Selfassembled amphiphilic DNAcholesterol/DNApeptide hybrid duplexes with liposomelike structure for doxorubicin delivery. Biomaterials. 2013;34(16):4183–4190. doi:10.1016/j.biomaterials.2013.02.04423480955
   PubMed Web of Science ®Google Scholar
• Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microrna targets. Cell. 2003;115(7):787–798.14697198
   PubMed Web of Science ®Google Scholar
• John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS. Human MicroRNA targets. PLoS Biol. 2004;2(11):e363. doi:10.1371/journal.pbio.002036315502875
   PubMed Web of Science ®Google Scholar
• Krek A, Grün D, Poy MN, et al. Combinatorial microRNA target predictions. Nat Genet. 2005;37(5):495–500. doi:10.1038/ng153615806104
   PubMed Web of Science ®Google Scholar
• Nicoloso MS, Spizzo R, Shimizu M, Rossi S, Calin GA. MicroRNAs – the micro steering wheel of tumour metastases. Nat Rev Cancer. 2009;9(4):293–302. doi:10.1038/nrc261919262572
   PubMed Web of Science ®Google Scholar
• Shiraishi T, Matsuyama S, Kitano H. Large-scale analysis of network bistability for human cancers. PLoS Comput Biol. 2010;6(7):e1000851. doi:10.1371/journal.pcbi.100085120628618
   PubMedGoogle Scholar
• Le Béchec A, Portales-Casamar E, Vetter G, et al. MIR@NT@N: a framework integrating transcription factors, microRNAs and their targets to identify sub-network motifs in a meta-regulation network model. BMC Bioinformatics. 2011;12:67. doi:10.1186/1471-2105-12-6721375730
   PubMedGoogle Scholar
• Chen Y, Sen J, Bathula SR, Yang Q, Fittipaldi R, Huang L. Novel cationic lipid that delivers siRNA and enhances therapeutic effect in lung cancer cells. Mol Pharm. 2009;6(3):696–705. doi:10.1021/mp800136v19267451
   PubMedGoogle Scholar
• Shi JF, Sun MG, Li XY, et al. A combination of targeted sunitinib liposomes and targeted vinorelbine liposomes for treating invasive breast cancer. J Biomed Nanotechnol. 2015;11(9):1568–1582.26485927
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 2001;25(4):402–408. doi:10.1006/meth.2001.126211846609
   PubMed Web of Science ®Google Scholar
• Ahn RW, Chen F, Chen H, et al. A novel nanoparticulate formulation of arsenic trioxide with enhanced therapeutic efficacy in a murine model of breast cancer. Clin Cancer Res. 2010;16(14):3607–3617. doi:10.1158/1078-0432.CCR-10-006820519360
   PubMed Web of Science ®Google Scholar
• Watt KI, Jaspers RT, Atherton P, et al. SB431542 treatment promotes the hypertrophy of skeletal muscle fibers but decreases specific force. Muscle Nerve. 2010;41(5):624–629. doi:10.1002/mus.2157320151464
   PubMedGoogle Scholar
• Huang RL, Yuan Y, Zou GM, Liu G, Tu J, Li Q. LPS-stimulated inflammatory environment inhibits BMP-2-induced osteoblastic differentiation through crosstalk between TLR4/MyD88/NF-κB and BMP/Smad signaling. Stem Cells Dev. 2014;23(3):277–289. doi:10.1089/scd.2013.034524050190
   PubMed Web of Science ®Google Scholar
• Liedtke C, Mazouni C, Hess KR, et al. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. J Clin Oncol. 2008;26(8):1275–1281. doi:10.1200/JCO.2007.14.414718250347
   PubMed Web of Science ®Google Scholar
• Podo F, Buydens LMC, Degani H, et al; FEMME Consortium. Triple-negative breast cancer: present challenges and new perspectives. Mol Oncol. 2010;4(3):209–229. doi:10.1016/j.molonc.2010.04.00620537966
   PubMed Web of Science ®Google Scholar
• Park JH, von Maltzahn G, Xu MJet al,. Cooperative nanomaterial system to sensitize, target, and treat tumors. Proc Natl Acad Sci U S A. 2010;107(3):981–986. doi:10.1073/pnas.090956510720080556
   PubMed Web of Science ®Google Scholar
• Shao S, Zhao X, Zhang X, et al. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner. Mol Cancer. 2015;14:28. doi:10.1186/s12943-014-0278-925645291
   PubMedGoogle Scholar
• Wang C, Zheng X, Shen C, Shi Y. MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells. J Exp Clin Cancer Res. 2012;31:58. doi:10.1186/1756-9966-31-9522713668
   PubMed Web of Science ®Google Scholar
• Zhao S, Han J, Zheng L, Yang Z, Zhao L, Lv Y. MicroRNA-203 regulates growth and metastasis of breast cancer. Cell Physiol Biochem. 2015;37(1):35–42. doi:10.1159/00043033126278219
   PubMedGoogle Scholar
• Taipaleenmäki H, Browne G, Akech J, et al. Targeting of Runx2 by miR-135 and miR-203 impairs progression of breast cancer and metastatic bone disease. Cancer Res. 2015;75(7):1433–1444. doi:10.1158/0008-5472.CAN-14-102625634212
   PubMed Web of Science ®Google Scholar
• Koning GA, Eggermont AMM, Lindner LH, ten Hagen TL. Hyperthermia and thermosensitive liposomes for improved delivery of chemotherapeutic drugs to solid tumors. Pharm Res. 2010;27(8):1750–1754. doi:10.1007/s11095-010-0154-220424894
   PubMed Web of Science ®Google Scholar
• Fang J, Nakamura H, Maeda H. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev. 2011;63(3):136–151. doi:10.1016/j.addr.2010.04.00920441782
   PubMed Web of Science ®Google Scholar
• Danquah MK, Zhang XA, Mahato RI. Extravasation of polymeric nanomedicines across tumor vasculature. Adv Drug Deliv Rev. 2011;63(8):623–639. doi:10.1016/j.addr.2010.11.00521144874
   PubMed Web of Science ®Google Scholar
• Modica-Napolitano JS, Aprille JR. Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells. Adv Drug Deliv Rev. 2001;49(1–2):63–70.11377803
   PubMed Web of Science ®Google Scholar
• Benjaminsen RV, Mattebjerg MA, Henriksen JR, Moghimi SM, Andresen TL. The possible “proton sponge “ effect of polyethylenimine (PEI) does not include change in lysosomal pH. Mol Ther. 2013;21(1):149–157. doi:10.1038/mt.2012.18523032976
   PubMed Web of Science ®Google Scholar
• Bramlage CP, Müller GA, Tampe B, et al. The role of bone morphogenetic protein-5 (BMP-5) in human nephrosclerosis. J Nephrol. 2011;24(5):647–655. doi:10.5301/JN.2011.633021319131
   PubMedGoogle Scholar
• Zhou S, Sun X, Yu L, et al. Differential expression and clinical significance of epithelial-mesenchymal transition markers among different histological types of triple-negative breast cancer. J Cancer. 2018;9(3):604–613. doi:10.7150/jca.1919029483966
   PubMedGoogle Scholar
• Bai JW, Chen MN, Wei XL, et al. The zinc-finger transcriptional factor Slug transcriptionally downregulates ERα by recruiting lysine-specific demethylase 1 in human breast cancer. Oncogenesis. 2017;6(5):e330. doi:10.1038/oncsis.2017.3828481366
   PubMedGoogle Scholar
• Travers MT, Barrett-Lee PJ, Berger U, et al. Growth factor expression in normal, benign, and malignant breast tissue. Br Med J (Clin Res Ed). 1988;296(6637):1621–1624.
   PubMedGoogle Scholar
• Romagnoli M, Belguise K, Yu Z, et al. Epithelial-to-mesenchymal transition induced by TGF-β1 is mediated by Blimp-1-dependent repression of BMP-5. Cancer Res. 2012;72(23):6268–6278. doi:10.1158/0008-5472.CAN-12-227023054396
   PubMed Web of Science ®Google Scholar